It is our heartiest welcome you to the “3rd International conference on Parkinson's Disease and Movement Disorders” during September 25-26, 2017 at Chicago, USA.
Parkinson’s 2017 is the leading gathering of neurologists, psychiatry, psychology researchers, and neurosurgeons with the theme of Research Strategies, propelled advancements and developments in Parkinson’s disease. Its main aim to deliver ideas for exchange of ideas and thoughts with the leading scientists which covers entire area of neurological disorder.
The live format of the conference will be accredited with CME and CPD Credits.
The objective of this session is to comprehend the inducement, Genesis and Diagnosis and prognosis including care giving of Parkinson’s disease and further hastening the revivification of Parkinson Disease.
Track 1: Epidemiology of Parkinsons Disease
Parkinsons disease is one of the well-known age related neurodegenerative disorder, second in recurrence just to Alzheimer's disease. Parkinsons disease also causes extensive injury of the motor or sensory pathways extending beyond the pigmental brain stem nuclei. Although the disease symptoms can be controlled by Levodopa but the etiology of the Parkinsons disease remains obscure. In the United States half a million of people are diagnosed as having PD and it is predicted to be triple over next 50 years. PD appears to be slightly more in men than in women usually ranging from 1.2:1 ratio upto 1.5:1. The Parkinsons disease market in US is expected to grow at a rate of 7.3% from sales of of $1.1 billion in 2012 to $2.3 billion in 2022. The population with Parkinsons disease incurred medical expenses of approximately $14.4 per year in United States. In U.S. 15% of people with PD were in the nursing homes as compared to 9 % are of all residents aged 75-84.
Related Conferences Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference| Neurology Conference | Neurologists Conference
6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017, at Amsterdam, Netherlands, 3rd International Conference Neurological disorders and Brain Injury during April 18-19, 2017 at London, UK, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 10th Annual Canadian Neuroscience Meeting during May 29-June , 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.
Associations on Parkinsons
UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, National Parkinsons Foundation, European Parkinsons Disease Association
Track 2: Neurocognitive Disorders
Neurocognitive disorder is a reduction of cognitive function in one of these areas, especially when physical changes can be seen to have occurred in the cerebrum, for example, after neurological disease, brain injury or drug use. It occurs due to PD with behaviour disturbance. According to the recent projects of the United Nations between 2000 to 2050 the people over 65 years of age will exceed 1.1 billion worldwide. For estimation by 2050 Parkinsons disease will be $285 billion in the USA.
Related Conferences Parkinsons Conference| Neurology Congress| Parkinsons Disease Conference| Neurology Conference | Neurologists Conference
7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 3rd International Conference on Neurological disorders and Brain Injury during April 18-19, 2017 at London, UK , 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA.
Associations on Parkinsons
European Parkinsons Disease Association, National Parkinsons Foundation, Parkinson Society Canada, European Neurological Society, Movement Disorders Society, UK Parkinsons Action Network, American Academy of Neurology
Track 3: Neuromuscular Disorders: Neuromuscular disorder is a disease that affects the peripheral nervous system which includes muscles, nerve-muscle junction, and peripheral nerves in the limbs and motor nerve cells in the spinal cord. Approximately 5600 people in the US are diagnosed with ALS each year. In US each year 750,000 people experience stroke, 11000 people suffer spinal cord injury, 500,000 people suffering from cerebral palsy, 270,000 with multiple sclerosis and 5.3 million with the after affects of a traumatic brain injury and amyotrophic lateral sclerosis.
Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 2nd 3rd International Conference on Neurological disorders and Brain Injury during April 18-19, 2017 at London, UK, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA.
Associations on Parkinsons
American Academy of Neurology, UK Parkinsons Action Network, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, National Parkinsons Foundation, European Parkinsons Disease Association
Track 4: Risk Factors of Parkinsons disease: Risk factor for the Parkinsons disease mainly depends on age, hereditary, sex and exposure to toxins. Men are more affected than women; 25%-45% are caused by the loss of dopamine which causes rigid movements. Advancing age is a factor that is more consistently associated with an increase in the Parkinsons disease; only 5%-10% of people get PD before age of 40. It involve some of the symptoms like anxiety, cognitive problems, tremor or shaking, depression, trouble sleeping, low voice, loss of smell etc. Now a day’s Head injury and Gene variation is also a factor for Parkinsons disease.
Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 3rd International Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.
Associations on Parkinsons
UK Parkinsons Action Network, Movement Disorders Society, , European Neurological Society, Parkinson Society Canada, European Parkinsons Disease Association, National Parkinsons Foundation, American Academy of Neurology
Track 5: Diagnostic and Neuroimaging for Parkinsons Disease: There is no direct treatment for Parkinsons disease as well any blood test or brain scan that confirms the diagnosis. Most PD treatments aim to restore the proper of the neurotransmitter acetylcholine and dopamine by increasing the dopamine levels. Treatment is totally based on the medical history and a neurological examination. At present there is no cure for PD, medications can lessen its symptoms and later stages surgery can be done. Parkinsons in the body; magnetic resonance imaging (MRI) is a test that produces very clear iamge of the human body without the use of X-rays. Instead of MRI uses a large magnet, radio waves, and a computer to produce these images. Medications are in three stages- first includes the drug which is known as levodopa which increase the dopamine in the brain, the second set of drugs eases some of the Parkinsons disease symptoms and the third set of drugs helps to control the non-motor symptoms including depression.
Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.
Associations on Parkinsons
National Parkinsons Foundation, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, European Parkinsons Disease Association
Track 6: Pathophysiology and pharmacology: The most prominent pathological lesion observed in PD occurs in the basal ganglia of the brain’s extra-pyramidal system. Non-PD patients and without nigrostriatal degeneration develope dyskinesias in response to dopaminergic. It is caused by gradual loss of nerve cells in the brain area called nigra and also by low and falling dopamine levels. The worldwide prevalence of Parkinson disease is anticipated to grow to 2.89 million cases worldwide by 2022.
Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.
Associations on Parkinsons European Parkinsons Disease Association, National Parkinsons Foundation, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada
Track 7: Parkinsons disease: Complications: Parkinsons disease is not thought to be a life threatening condition, but rather it has a vast effect of your personal satisfaction. With time, the sickness can bring about issues with speech, movement disorder, and brain functioning. The major complication in Parkinsons disease are blood pressure changes, depression, emotional changes, thinking difficulties, fatigue, sexual dysfunction, smell dysfunction, pain and sleep disorders.
Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.
Associations on Parkinsons Parkinson Society Canada, European Neurological Society, Movement Disorders Society, American Academy of Neurology, UK Parkinsons Action Network, National Parkinsons Foundation, European Parkinsons Disease Association
Track 8: Managing life with Parkinsons disease: It is important to develope a solid PD management plan because PD is a chronic disease. Managing with Parkinsons disease includes building a health care team with proper doctors, proper intake of medications, exercises, nutrition and sleep.
Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy ,8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.
Associations on Parkinsons European Neurological Society, Parkinson Society Canada, European Parkinsons Disease Association, National Parkinsons Foundation, Movement Disorders Society, American Academy of Neurology, UK Parkinsons Action Network
Track 9: Novel Insights and therapeutics for Parkinsons disease: Parkinsons disease is the essential growth driver of the worldwide Parkinsons disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. The therapeutics of Parkinsons Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinsons disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.
Related Conference Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA ,13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.
Associations on Parkinsons UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, European Parkinsons Disease Association, National Parkinsons Foundation, Parkinson Society Canada
Track 10: Neural Transplantation: Neural transplantation is the transplantation of nerve cells and tissues into the brain and spinal cord. The cell replacement for Parkinsons Disease is based on two hypothesis- firstly the early symptoms of PD are dependent on the loss of the dopaminergic neurons in the nigrostriatal pathways and secondly the dopaminergic neurons and gathered into dopamine deficient striatum can replace those neurons which has been lost during the disease process and can reverse some extent of the major symptoms of Parkinson disease.
Related Conference Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA.
Associations on Parkinsons Parkinson Society Canada, UK Parkinsons Action Network, National Parkinsons Foundation, European Parkinsons Disease Association, European Neurological Society, American Academy of Neurology, Movement Disorders Society
Track 11: Gene Therapy: It is a technique which aims at treating diseases by genetically modifying population of cells into the patient body instead of using drugs and surgery to prevent from any disorder. Various methods have been developed for the gene delivery to the target cells which includes viral and non-viral systems. It is a creation of producing new cells that will produce a specific neurotransmitter which is dopamine to protect the neural system and then these cells are transplanted to the patient having Parkinsons disease because the neurons cannot be renewed further. Some important reasons are there for focusing gene therapy which includes firstly there is no cure for PD disease; secondly some genes which are identified can modulate the neuron phenotype.
Related Conference Parkinsons Conference |Neurology Congress |Parkinsons Disease Conference | Neurology Conference | Neurologists Conference
1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.
Associations on Parkinsons
Movement Disorders Society, Parkinson Society Canada, American Academy of Neurology, European Neurological Society, UK Parkinsons Action Network, National Parkinsons Foundation, European Parkinsons Disease Association
Track 12: Paediatric Movement disorders: Paediatric movement disorder is a moderately new and developing field of child neurology. While hypokinetic scatters, for example, Parkinson disease prevails in adults. There are many genetic disease which cause secondary movement disorders in childhood. Propels in paediatric movement disorder have been made by solidifying movement disorder definitions, growing the range of clinical phenotypes, understanding genetic reasons for movement disorders, and thoroughly assessing treatment adequacy for normal movement disorders. The central nervous systems typically implicated in disorders of movement are the basal and frontal cortex. Five areas were highlighted these advances: consensus definitions, newly found PRRT2 mutation, clinical and genetic range of GLUT-1 lack and neurodegeneration with brain iron aggregation (NBIA) issue, and exhaustive behavioural interventions for tics (CBIT).
Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference |Neurology Conference | Neurologists Conference
2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA.
Associations on Parkinsons European Parkinsons Disease Association, Movement Disorders Society, National Parkinsons Foundation, Parkinson Society Canada, American Academy of Neurology, European Neurological Society, UK Parkinsons Action Network
Theme: Research Strategies, propelled advancements and developments in Parkinson’s disease.
On behalf of the Conference Organizing Committee, It is our heartiest welcome you to the “3rd International conference on Parkinson's Disease and Movement Disorders” during September 25-26, 2017 in Chicago, USA.
Importance and Scope:
Parkinson’s disease is a progressive disease of the nervous system set apart by tremor, muscle rigidity, and moderate, imprecise movement, chiefly affecting aged and elderly individuals. It is connected with degeneration of the basal ganglia of the brain and deficiency of the neurotransmitter dopamine.
Parkinson’s disease is a progressive neurological disorder which is caused due to neurodegeneration.About 10 million of people are suffering from Parkinson’s disease globally. The global prevalence in 2012 was approximately 2.18 million cases in worldwide where $1.15 billion in US market. The Parkinson’s disease market in US is expected to grow at a rate of 7.3% from sales of of $1.1 billion in 2012 to $2.3 billion in 2022.Treatment market value is being expected to increase from $3.6 billion in 2012 to $5.3 billion in 2022. US- has the largest Parkinson’s disease therapeutics market share of 44% by 2022 which is expanding from 32% in 2012 and this will be followed by Japan, Brazil and Germany with shares of 13%, 11% and 10%. Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. In the United Kingdom approximately 127,000 people are suffering from PD. Male got 50% higher risk than females, however 4 to 5% of the cases the sufferer is younger than 40 years and it is known as Young-onset Parkinson’s disease. NINDS funded about $90 million out of $135 million in NIH-supported PD research in USA.
For more details, please visit: http://parkinsons.conferenceseries.com/
Why Chicago:
Parkinson’s 2017 are the leading meeting dedicated to Neurologists and Neurosurgeons researchers with the theme “
Goal of Parkinson’s2017 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in Parkinson’s Disease and Movement Disorders and share the cross-cultural experiences of various treatment procedures.
We strive to make Parkinson’s 2017 a success, with your support and high quality talks from both Parkinson’s disease and Movement Disorders communities. During the conference, we assure you that you will experience world class facilities and hospitality at the conference.
Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 40%-60% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease
Conference Highlights:
Epidemiology of Parkinson’s disease
Neurocognitive Disorders
Neuromuscular Disorders
Risk factors of Parkinson’s disease
Diagnostic and Neuroimaging for Parkinson’s disease
Pathophysiology and pharmacology
Parkinson’s disease: Complications
Managing life with Parkinson’s disease
Novel Insights and therapeutics for Parkinson’s disease
Neural Transplantation
Gene therapy
Paediatric Movement disorders
Why to attend?
Adjoin your Target Scientists; Professors, individuals from around the globe focused on learning about Parkinson’s Disease and Movement Disorders, this is your exclusive best opportunity to reach the largest assemblage of participants from all over the world.. World-renowned speakers, the latest discoveries and most recent updates in Parkinson Disease and Movement Disorders fields, which are hallmarks of this conference.
Major Associations around the globe:
-
National Parkinson Foundation
-
American Parkinson Disease Association (APDA)
-
Parkinson’s disease Foundation
-
Movement Disorder Society of Australia
-
Parkinson's Unity Walk
-
Movement Disorder Society of Japan
-
Moroccan Neurological Society Movement Disorders Group
-
Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia
-
Ecuador Movement Disorders Group
-
Austrian Parkinson's Disease Society
-
Danish Movement Disorder Society
-
International Parkinson and Movement Disorder Society
-
Parkinson’s Disease and Movement Disorders Society of India
Around 25 associations of Parkinson Disease are there in USA
-
Parkinson Association of the Rockies
-
Brian Grant Foundation
-
The Michael J. Fox Foundation
-
The Foundation for Mitochondrial Medicine
-
The International Parkinson and Movement Disorder Society
-
Parkinson Alliance
-
Parkinson's Action Network (PAN)
-
Bachmann-Strauss Dystonia & Parkinson Foundation
-
Parkinson's Resource Organization
-
International Association of Parkinsonism
-
Booth Gardner Parkinson’s Care Center
-
Canadian Movement Disorders Group
-
Dallas area Parkinsonism Society
-
Indian Parkinson Foundation- The Climb
-
New Mexico Parkinson’s Disease Coalition
-
Wisconsis Parkinsons Foundation
Top universities 500 globally working in the field of Parkinson Disease
-
University of Bath
-
The University of Queensland
-
University of Bristol
-
University of Cambridge
-
The Imperial College of Science and Medicine
-
Duke University
-
University of Milan
-
Karolinska Institute
-
University of Hamburg
-
The University of Edinburgh
-
University of Munich
-
University of Rochester
-
University of Zurich
-
Leiden University
-
University of Bristol
-
University of Helsinki
-
Uppsala University
-
University of Freiburg
-
University of Frankfurt
-
University of Chicago Medicine
Top universities in USA working in the field of Parkinson Disease
-
University of California
-
University of Kansas Medical Center
-
University of South Alabama
-
University of Florida
-
University of Miami
-
Georgia Health Sciences University
-
Emory University
-
Northwestern University Movement Disorders Center
-
Johns Hopkins Parkinson's Disease&Movement Disorders Center
-
New York University Langone Medical Center
-
University of Rochester Medical Center
-
Duke University Medical Center
-
University of North Carolina
-
Oregon Health & Science University Parkinson Center of Oregon
-
University of Pennsylvania
-
Vanderbilt University Medical Center
-
Baylor College of Medicine
Top Universities in Chicago
University of Chicago
University of Illionois at Chicago
Loyola University Chicago
DePaul University
Columbia College Chicago
Chicago State University
Northeastern Illinois University
Roosevelt University
Saint Xavier University
North Park University
National Louis Uniersity
Harold Washington College
Truman College
Rush University
Feinberg school of Medicine
American College of Education
Kendall College
Top Hospitals in Chicago
Northwestern Memorial Hospital
Advocate Christ Medical Center
Northshore Evanston Hospital
Central DuPage Hospital
Mercy Hospital and Medical Center
Saint Joseph Hospital, Chicago
Mount Sinai Hospital, Chicago
Weiss Memorial Hospital Chicago
Norwegian- American Hospital, Chicago
Industries Associated with Parkinson Research
-
Dainippon Sumitomo Pharma
-
BioSante Pharmaceuticals
-
GlaxoSmithKline (GSK)
-
Boehringer Ingelheim
Harish Pant
Guy H. Fontaine
A V Srinivasan
Tyrone Genade
Susan Scanland
Azza A. Ali 
Jayakumar Rajadas 
Zang-Hee Cho
Yawu Liu
Sajjad Ali
Judit Subirana-Mirete
Elamir Elsherif
Pablo Guijarro
Maia Machvariani-Tsereteli
Evelyn M. Garcia
José L. Ochoa
Emanuel Kanal
Héllio Danny Nóbrega de Souza
Giovanni Antioco Putzu
Ann Marie Gillie
Rajendra Badgaiyan